Form 4: BIOLIFE SOLUTIONS CHRO Sells Shares for Tax Obligations

BIOLIFE SOLUTIONS' Chief Human Resources Officer, Sarah Aebersold, sold 219 shares of common stock at $20.74 per share to cover tax withholding obligations.

Summary

• Sarah Aebersold, Chief Human Resources Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 219 shares of common stock.
• The shares were sold at a price of $20.74 per share.
• The sale occurred on March 3, 2026.
• Following this transaction, Sarah Aebersold beneficially owns 93,360 shares of common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan, adopted on February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine, pre-planned transaction for tax purposes, not indicative of a change in the insider's view of the company's value or future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that routine insider sales, particularly those pre-planned under Rule 10b5-1 to cover tax obligations from restricted stock vesting, are common across industries and typically do not signal a change in management's confidence in the company's prospects. Such transactions are a standard part of executive compensation and tax planning.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, pre-planned insider transaction for tax purposes and does not suggest a change in company fundamentals or management's outlook.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider sale by the Chief Human Resources Officer to cover tax obligations related to restricted stock vesting. Such transactions are common and generally do not reflect a change in the company's fundamental value or the insider's long-term confidence. Therefore, a seasoned investor or institution would likely maintain their current position, as this event provides no new material information to warrant a change in investment recommendation.

Keywords

BIOLIFE SOLUTIONS, BLFS, Form 4, Insider Trading, Stock Sale, Tax Withholding, Rule 10b5-1, Chief Human Resources Officer, Sarah Aebersold